Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 298

1.

Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.

Twarock S, Freudenberger T, Poscher E, Dai G, Jannasch K, Dullin C, Alves F, Prenzel K, Knoefel WT, Stoecklein NH, Savani RC, Homey B, Fischer JW.

Mol Cancer. 2011 Mar 23;10:30. doi: 10.1186/1476-4598-10-30.

2.

Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.

Twarock S, Tammi MI, Savani RC, Fischer JW.

J Biol Chem. 2010 Jul 23;285(30):23276-84. doi: 10.1074/jbc.M109.093146. Epub 2010 May 12.

3.

Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues.

Zhang G, Zhang Q, Zhang Q, Yin L, Li S, Cheng K, Zhang Y, Xu H, Wu W.

J Cancer Res Clin Oncol. 2010 Apr;136(4):587-94. doi: 10.1007/s00432-009-0693-2. Epub 2009 Oct 13.

PMID:
19823871
4.

Synthesis of hyaluronan in oesophageal cancer cells is uncoupled from the prostaglandin-cAMP pathway.

Twarock S, Röck K, Sarbia M, Weber AA, Jänicke RU, Fischer JW.

Br J Pharmacol. 2009 May;157(2):234-43. doi: 10.1111/j.1476-5381.2009.00138.x. Epub 2009 Mar 26.

5.

4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3.

Kultti A, Pasonen-Seppänen S, Jauhiainen M, Rilla KJ, Kärnä R, Pyöriä E, Tammi RH, Tammi MI.

Exp Cell Res. 2009 Jul 1;315(11):1914-23. doi: 10.1016/j.yexcr.2009.03.002. Epub 2009 Mar 13.

PMID:
19285976
6.

Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma.

Li X, Wu Z, Mei Q, Li X, Guo M, Fu X, Han W.

Br J Cancer. 2013 Oct 15;109(8):2266-78. doi: 10.1038/bjc.2013.548. Epub 2013 Sep 10.

7.

HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.

Tofuku K, Yokouchi M, Murayama T, Minami S, Komiya S.

Int J Oncol. 2006 Jul;29(1):175-83.

PMID:
16773198
8.

Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.

Li Y, Fu L, Li JB, Qin Y, Zeng TT, Zhou J, Zeng ZL, Chen J, Cao TT, Ban X, Qian C, Cai Z, Xie D, Huang P, Guan XY.

Gastroenterology. 2014 Jun;146(7):1701-13.e9. doi: 10.1053/j.gastro.2014.02.029. Epub 2014 Feb 21.

PMID:
24561231
9.

Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.

Urakawa H, Nishida Y, Wasa J, Arai E, Zhuo L, Kimata K, Kozawa E, Futamura N, Ishiguro N.

Int J Cancer. 2012 Jan 15;130(2):454-66. doi: 10.1002/ijc.26014. Epub 2011 Apr 25.

10.

Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.

Gong H, Song L, Lin C, Liu A, Lin X, Wu J, Li M, Li J.

Clin Cancer Res. 2013 Mar 1;19(5):1083-93. doi: 10.1158/1078-0432.CCR-12-3169. Epub 2013 Jan 14.

11.

Inhibition effects of all trans-retinoic acid on the growth and angiogenesis of esophageal squamous cell carcinoma in nude mice.

Lu TY, Li WC, Chen RY, Fan QX, Wang LX, Wang RL, Lu SX, Meng H.

Chin Med J (Engl). 2011 Sep;124(17):2708-14.

PMID:
22040429
12.

Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib.

Wang L, Guo B, Wang R, Jiang Y, Qin S, Liang S, Zhao Y, Guo W, Li K, Fan X.

Clin Sci (Lond). 2012 Jan;122(1):13-24. doi: 10.1042/CS20110230.

PMID:
21751967
13.

Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.

Piccioni F, Malvicini M, Garcia MG, Rodriguez A, Atorrasagasti C, Kippes N, Piedra Buena IT, Rizzo MM, Bayo J, Aquino J, Viola M, Passi A, Alaniz L, Mazzolini G.

Glycobiology. 2012 Mar;22(3):400-10. doi: 10.1093/glycob/cwr158. Epub 2011 Oct 28.

PMID:
22038477
14.

Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.

Rahadiani N, Ikeda J, Makino T, Tian T, Qiu Y, Mamat S, Wang Y, Doki Y, Aozasa K, Morii E.

Ann Surg Oncol. 2010 May;17(5):1311-23. doi: 10.1245/s10434-009-0895-5. Epub 2010 Jan 12.

PMID:
20066519
15.

RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.

Faried A, Faried LS, Kimura H, Nakajima M, Sohda M, Miyazaki T, Kato H, Usman N, Kuwano H.

Eur J Cancer. 2006 Jul;42(10):1455-65. Epub 2006 Jun 5.

PMID:
16750623
16.

Continuous taurocholic acid exposure promotes esophageal squamous cell carcinoma progression due to reduced cell loss resulting from enhanced vascular development.

Sato S, Yamamoto H, Mukaisho K, Saito S, Hattori T, Yamamoto G, Sugihara H.

PLoS One. 2014 Feb 14;9(2):e88831. doi: 10.1371/journal.pone.0088831. eCollection 2014.

17.

Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.

Qin YR, Tang H, Xie F, Liu H, Zhu Y, Ai J, Chen L, Li Y, Kwong DL, Fu L, Guan XY.

Clin Cancer Res. 2011 Jan 1;17(1):46-55. doi: 10.1158/1078-0432.CCR-10-1155. Epub 2010 Nov 17.

18.

Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.

Ikuta K, Ota T, Zhuo L, Urakawa H, Kozawa E, Hamada S, Kimata K, Ishiguro N, Nishida Y.

Int J Cancer. 2017 Jan 15;140(2):469-479. doi: 10.1002/ijc.30460. Epub 2016 Oct 18.

PMID:
27706810
19.

Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.

Tian X, Ma P, Sui CG, Meng FD, Li Y, Fu LY, Jiang T, Wang Y, Jiang YH.

FEBS J. 2014 Jun;281(12):2805-19. doi: 10.1111/febs.12822. Epub 2014 May 21.

20.

A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone.

Kakizaki I, Kojima K, Takagaki K, Endo M, Kannagi R, Ito M, Maruo Y, Sato H, Yasuda T, Mita S, Kimata K, Itano N.

J Biol Chem. 2004 Aug 6;279(32):33281-9. Epub 2004 Jun 9.

Supplemental Content

Support Center